Related Experiment Video
Updated: Aug 7, 2026
12:13
Single-Molecule Imaging of Nuclear Transport
Published on: June 10, 2010
Nuclear transport as a target for cell growth
Tweeny R Kau1, Pamela A Silver
1Dept of Biological Chemistry and Molecular Pharmacology, Harvard Medical School and Dept of Cancer Biology, The Dana Farber Cancer Institute, Boston, MA 02115, USA.
Drug Discovery Today
|February 5, 2003
Summary
Targeting key cell growth proteins like p53 to specific cellular locations offers therapeutic potential. This study explores small-molecule inhibitors and peptide aptamers for controlling protein localization and function.
Area of Science:
- Cell Biology
- Molecular Biology
- Drug Discovery
Background:
- Cellular localization of proteins, such as tumor suppressor p53 and nuclear factor kappa B, critically regulates cell growth.
- Altering protein localization (cytoplasmic or nuclear sequestration) is a proposed therapeutic strategy.
- Limited nuclear transport inhibitors currently exist, highlighting a need for new approaches.
Purpose of the Study:
- To investigate the therapeutic potential of small-molecule inhibitors that induce protein sequestration in the nucleus or cytoplasm.
- To explore peptide aptamer technology for artificial targeting of proteins to specific cellular compartments.
- To understand how modulating protein localization impacts cellular functions.
Main Methods:
- Review of existing literature on nuclear transport inhibitors.
- Exploration of small-molecule compounds designed to sequester target proteins.
- Discussion of peptide aptamer strategies for protein relocalization.
Main Results:
- Small-molecule inhibitors can effectively cause target proteins to accumulate in either the nucleus or cytoplasm.
- Peptide aptamer technology provides a method for artificial control over protein cellular localization.
- Modulating protein localization presents a viable strategy for therapeutic intervention.
Conclusions:
- Controlling protein localization via small-molecule inhibitors or peptide aptamers is a promising therapeutic avenue.
- Further research into these methods could lead to novel treatments for diseases involving aberrant cell growth.
- Targeting protein transport pathways offers new possibilities in drug development.
More Related Videos
10:10Spatiotemporally Controlled Nuclear Translocation of Guests in Living Cells Using Caged Molecular Glues as Photoactivatable Tags
Published on: January 17, 2019
11:39Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
Published on: October 23, 2019
Related Concept Videos
01:34Nuclear Protein Sorting
Nuclear protein sorting is the selective trafficking of histones, polymerases, gene regulatory proteins into the nucleus and exporting RNAs and ribosomes to the cytosol. It is a tightly controlled process that regulates gene expression within a cell.
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...
01:46Nuclear Localization Signals and Import
Proteins targeted to the nucleus carry short stretches of amino acid sequences called the nuclear localization signal or NLS. Classical nuclear localization signals are of two types: monopartite and bipartite NLS. Monopartite classical NLS (cNLS) consists of a single cluster of 4-8 amino acids. Bipartite cNLS consists of two clusters of 2-3 amino acids and a 9-12 residue long proline-rich linker bridging the two clusters. Signal clusters are rich in positively charged amino acids such as...
01:42Nuclear Export
The nucleus restricts several proteins within and allows others to pass. The restricted proteins possess a nuclear retention sequence or NRS, anchoring them to the nuclear lamins and preventing their transport to the cytosol. The non-restricted proteins, after their synthesis, are transported to their site of action, such as the cytosol or other organelles, with the help of nuclear export signals or NES.
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
01:42Directionality of Nuclear Transport
Ras-related nuclear protein or Ran is a small G protein that cycles between its GTP and GDP bound states. Ran specific regulators, a Ran GTPase Activating Protein or RanGAP present in the cytosol and a Ran guanine nucleotide exchange factor or RanGEF present inside the nucleus regulate GTP/GDP exchange. A high concentration of GTP inside the cells, in addition to this asymmetric distribution of Ran-specific regulators, leads to a higher RanGTP concentration inside the nucleus. This...
01:45Regulation of Nuclear Protein Sorting
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
02:31Nuclear Export of mRNA
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...